Lithium studies and manic-depressive illness.
D000342:Affective Symptoms / Q000378:metabolism / Q000517:prevention & control; D000818:Animals; D000928:Antidepressive Agents / Q000627:therapeutic use; D001693:Biological Transport, Active / Q000187:drug effects; D001714:Bipolar Disorder / Q000188:drug therapy*; D001923:Brain Chemistry / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D002986:Clinical Trials as Topic; D003431:Cross-Cultural Comparison; D003863:Depression / Q000188:drug therapy / Q000517:prevention & control; D004569:Electroencephalography; D005069:Evaluation Studies as Topic; D006801:Humans; D008094:Lithium / Q000494:pharmacology / Q000627:therapeutic use*; D009474:Neurons / Q000187:drug effects; D010919:Placebos; D051381:Rats; D012559:Schizophrenia / Q000188:drug therapy; D012964:Sodium / Q000378:metabolism; D009435:Synaptic Transmission / Q000187:drug effects; D013961:Thyroid Gland / Q000187:drug effects
D000928:Antidepressive Agents; D002395:Catecholamines; D010919:Placebos; D008094:Lithium; D012964:Sodium